SCLX scilexholding.com Net Financial Result

SCLX (scilexholding.com) - company brandmark

The daily price chart for Scilex Holding Company (SCLX) reflects profit dynamics, which currently stand at -0.45. Scilex Holding Company (SCLX) specializes in developing non-opioid pain management solutions. The expert community highly values the reliability of their developments, confirming the company's status as an authoritative market player. The growth strategy relies on expanding relationships with suppliers and pharmacies to implement safe therapy methods.

Scilex Holding Company (SCLX): Net Profit from 04/28/2023 to 11/01/2026

Financial and market metric breakdowns for Scilex (SCLX)

- stock value and consensus price forecast:
Market Price Scilex Holding Company, Inc.|SCLX - Price Target Chart
- market capitalization data:
Market Capitalization Scilex Holding Company, Inc.|SCLX - Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share Scilex Holding Company|SCLX - Book Capitalization|Market Capitalization to Book Value scilexholding.com|SCLX - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Scilex Holding Company|SCLX - Long-Term Debt to Capital|Current Liabilities to Capital Scilex Holding|SCLX - Company Total Debt|Debt to Book Value Ratio Scilex Holding Company, Inc.|SCLX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Scilex Holding Company|Intermediate Coverage Ratio scilexholding.com
- net income and valuation ratios data:
SCLX - Company Net Income
Summary company analysis:Scilex Holding Company, Inc.
Finished products of Scilex Holding Company

Scilex Holding Company (SCLX) profit reflects the actual financial result net of all operating and debt obligations. This indicator of the company's financial success allows for the real-time tracking of cash flows, bypassing the delays associated with quarterly reporting. The metric is calculated by offsetting current revenues against expenses, revealing hidden cash gaps. This is critical for Scilex Holding Company (SCLX) when scaling the production of non-opioid analgesics. The steady growth of the curve confirms the commercial efficiency of the innovative patches.

Key competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|regencellbioscience.com (RGC) - Net Financial Result|Net Profit AXSM|Net Income ACADIA Pharma ACAD|Net Profit XENE (Xenon Pharmaceuticals Inc)|Net Financial Result Viking Therapeutics Corp (VKTX)|SUPN - Company Net Income|CPRX: Company Net Income|DNLI: Net Profit|Company Net Income Harmony Biosciences Inc (HRMY)|Net Income BHVN|Company Profit AMLX (Amylyx Corp)|Net Income TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Final Profit|Net Profit AVXL (Anavex Life Sciences Corp.)|Final Profit CBLL|PRTA - Company Net Income|Company Net Income Alector, Inc.|Annexon, Inc. (ANNX) - Company Net Income|OMER (Omeros) - Company Net Income|NGNE (Neurogene) - Net Profit|Company Profit ACIU (AC Immune S.A.)|Net Profit VYGR|Net Financial Result Neumora Corp|Company Net Income Tevogen Bio Holdings TVGN|ACOG: Company Profit|Cognition Therapeutics - Net Profit|Annual Net Income Inhibikase Therapeutics Inc (IKT)|SAVA (Cassava) - Net Income|Assertio - Final Profit|COYA (Coya Therapeutics Inc) - Net Profit|Net Income VistaGen Therapeutics Inc (VTGN)|Company Net Income Ovid Therapeutics Inc. (OVID)|ABOS - Company Net Income|Company Net Income CervoMed Inc CRVO|ATHE - Net Income|CLNN - Company Net Income|Profit After Tax PEPG|JUNS: Net Profit|Relmada Therapeutics Inc (RLMD) - Net Profit|Company Net Income Annovis Bio Corp|Company Profit GRCE (Grace Tx)|Net Income AIFF (Firefly Neuroscience, Inc)|KLTO - Company Net Income|Company Net Income NeuroSense Therapeutics Ltd. NRSN|Net Financial Result Reviva Pharmaceuticals Holdings Inc. (RVPH)|MetaVia, Inc. - Net Profit|NeurAxis Inc (NRXS) - Net Income|heliusmedical.com (HSDT) - Company Net Income|PASG (Passage Bio) - Company Net Income|Net Income NEUP|Company Profit NERV (Minerva Neurosciences Inc)|Company Net Income Athira (ATHA)|Addex - Company Profit|Net Profit ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Company Net Income|PTIX: Net Income|KTTA - Net Profit|cortigent.com (CRGT) - Company Net Income|Avenue Therapeutics Inc - Final Profit|Company Net Income Brainstorm Cell|Company Net Income caratherapeutics.com CARA|Company Net Income Chromocell Therapeutics Corp. (CHRO)|Net Financial Result eliemtx.com|Net Profit ITCI (Intra-Cellular Therapies, Inc.)|LBPH - Net Income|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|SAGE (Sage Therapeutics Inc.) - Company Net Income|SNPX (Neurotrope) - Net Profit|Company Net Income Trevena Inc TRVN|Net Income VIGL (Vigil Neuroscience)|Anew Medical Inc. - Company Profit|Cerevel Therapeutics, Inc. - Net Income